A detailed history of Price T Rowe Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 17,091,951 shares of PFE stock, worth $500 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
17,091,951
Previous 25,139,969 32.01%
Holding current value
$500 Million
Previous $698 Million 31.45%
% of portfolio
0.06%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $203 Million - $238 Million
-8,048,018 Reduced 32.01%
17,091,951 $478 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $140 Million - $161 Million
-5,404,088 Reduced 17.69%
25,139,969 $698 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $483 Million - $627 Million
-18,470,625 Reduced 37.68%
30,544,057 $879 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $527 Million - $616 Million
16,418,085 Added 50.37%
49,014,682 $1.63 Billion
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $159 Million - $184 Million
-4,401,435 Reduced 11.9%
32,596,597 $1.2 Billion
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $44.3 Million - $57.7 Million
1,125,491 Added 3.14%
36,998,032 $1.51 Billion
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $24.9 Million - $32.5 Million
-595,448 Reduced 1.63%
35,872,541 $1.84 Billion
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $66.9 Million - $81.7 Million
1,529,779 Added 4.38%
36,467,989 $1.6 Billion
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $18.8 Million - $22.3 Million
-404,839 Reduced 1.15%
34,938,210 $1.83 Billion
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $362 Million - $449 Million
-7,915,667 Reduced 18.3%
35,343,049 $1.83 Billion
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $168 Million - $249 Million
4,065,502 Added 10.37%
43,258,716 $2.55 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $585 Million - $751 Million
14,898,367 Added 61.32%
39,193,214 $1.69 Billion
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $36.9 Million - $41.8 Million
1,026,903 Added 4.41%
24,294,847 $951 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $277 Million - $313 Million
-8,284,042 Reduced 26.26%
23,267,944 $843 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $1.06 Billion - $1.34 Billion
31,551,986 New
31,551,986 $1.16 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $164B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.